Avantor Inc
NYSE:AVTR
Intrinsic Value
Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. [ Read More ]
The intrinsic value of one AVTR stock under the Base Case scenario is 26.25 USD. Compared to the current market price of 25.46 USD, Avantor Inc is Undervalued by 3%.
Valuation Backtest
Avantor Inc
Run backtest to discover the historical profit from buying and selling AVTR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Avantor Inc
Current Assets | 2.4B |
Cash & Short-Term Investments | 262.9m |
Receivables | 1.2B |
Other Current Assets | 971.8m |
Non-Current Assets | 10.6B |
PP&E | 737.5m |
Intangibles | 9.5B |
Other Non-Current Assets | 358.3m |
Current Liabilities | 1.5B |
Accounts Payable | 625.9m |
Accrued Liabilities | 183.3m |
Other Current Liabilities | 671.1m |
Non-Current Liabilities | 6.2B |
Long-Term Debt | 5.3B |
Other Non-Current Liabilities | 963.1m |
Earnings Waterfall
Avantor Inc
Revenue
|
7B
USD
|
Cost of Revenue
|
-4.6B
USD
|
Gross Profit
|
2.4B
USD
|
Operating Expenses
|
-1.5B
USD
|
Operating Income
|
883.7m
USD
|
Other Expenses
|
-562.6m
USD
|
Net Income
|
321.1m
USD
|
Free Cash Flow Analysis
Avantor Inc
AVTR Profitability Score
Profitability Due Diligence
Avantor Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Avantor Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
AVTR Solvency Score
Solvency Due Diligence
Avantor Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Score
Avantor Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AVTR Price Targets Summary
Avantor Inc
According to Wall Street analysts, the average 1-year price target for AVTR is 27.53 USD with a low forecast of 20.2 USD and a high forecast of 31.5 USD.
Ownership
AVTR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
AVTR Price
Avantor Inc
Average Annual Return | 20.13% |
Standard Deviation of Annual Returns | 45.96% |
Max Drawdown | -61% |
Market Capitalization | 17.2B USD |
Shares Outstanding | 679 200 000 |
Percentage of Shares Shorted | 4.33% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
Contact
IPO
Employees
Officers
The intrinsic value of one AVTR stock under the Base Case scenario is 26.25 USD.
Compared to the current market price of 25.46 USD, Avantor Inc is Undervalued by 3%.